Your browser doesn't support javascript.
loading
Efficacy and safety of saroglitazar in managing hypertriglyceridemia in type-2 diabetes: A meta-analysis.
Dutta, Deep; Bhattacharya, Saptarshi; Surana, Vineet; Aggarwal, Sameer; Singla, Rajiv; Khandelwal, Deepak; Sharma, Meha.
Afiliação
  • Dutta D; Department of Endocrinology, Center for Endocrinology, Diabetes, Arthritis & Rheumatism (CEDAR) Super-speciality Clinics, Dwarka, New Delhi, India. Electronic address: deepdutta2000@yahoo.com.
  • Bhattacharya S; Department of Endocrinology, Max Superspeciality Hospitals, Patparganj, New Delhi, India.
  • Surana V; Department of Endocrinology, Manipal Hospitals, Dwarka, New Delhi, India.
  • Aggarwal S; Department of Endocrinology, Apex Superspeciality, Rohtak, India.
  • Singla R; Department of Endocrinology, Kalpavriksha Healthcare, Dwarka, New Delhi, India.
  • Khandelwal D; Department of Endocrinology, Maharaj Agrasen Hospital, New Delhi, India.
  • Sharma M; Department of Rheumatology, CEDAR Superspeciality Clinics, Dwarka, New Delhi, India.
Diabetes Metab Syndr ; 14(6): 1759-1768, 2020.
Article em En | MEDLINE | ID: mdl-32937280
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenilpropionatos / Pirróis / Hipertrigliceridemia / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenilpropionatos / Pirróis / Hipertrigliceridemia / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2020 Tipo de documento: Article